Davis Polk advised the joint bookrunners in connection with a primary offering by BR Properties S.A. of common shares for an aggregate amount of R$1.05 billion (approximately US$247.5…
Davis Polk advised the representatives of the several underwriters in connection with Synchrony Financial’s SEC-registered offering of 30,000,000 depositary shares, each representing a 1…
Davis Polk advised the underwriters on a $750 million SEC-registered offering of 2.375% senior notes due 2025 by Fifth Third Bancorp. The net proceeds from the offering totaled…
Davis Polk advised the underwriters in connection with the offering of $1.25 billion aggregate principal amount of 1.750% bonds due 2024, issued by the Province of British Columbia.
The…
Davis Polk advised the underwriters in an SEC-registered public offering by Fifth Third Bancorp of 10,000,000 depositary shares, each representing a 1/1,000th ownership interest in a share…
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Insight Enterprises, Inc. of $300 million aggregate principal amount of its 0.750% convertible senior…
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell International Inc. of $600 million aggregate principal amount of its 2.150%…
Davis Polk is acting as special tax counsel to Pfizer Inc. on the combination of its off-patent branded and generic established medicines business, Upjohn, with Mylan N.V. Under the terms…
Davis Polk advised the underwriters in connection with Synchrony Financial’s SEC-registered offering of $750 million aggregate principal amount of 2.850% senior notes due 2022.
Based…
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of €5 billion aggregate principal amount of notes by Medtronic Global…